MAPT and Atrophy: Further investigations demonstrated that the specific distribution of the tau‐PET signal was a strong indicator of the topography of future atrophy (at the single patient level) and that the relationship between baseline tau‐PET and subsequent atrophy tended to be stronger in younger patients.80